Quinolinic acid protects rat cerebellar granule cells from glutamate-induced apoptosis

Neurosci Lett. 1998 Jan 30;241(2-3):180-4. doi: 10.1016/s0304-3940(97)00980-4.

Abstract

The effects of quinolinic acid (QUIN) on glutamate-induced excitotoxicity were examined in primary cultures of rat cerebellar granule neurons. Exposing these neurons to QUIN (< or =2.5 mM) in the presence of glucose and Mg2+ had no effect on their viability. Although pretreating neurons with QUIN (10 microM) for 6 h did not reduce necrotic death induced by glutamate exposure in the absence of glucose and Mg2+, QUIN pretreatment significantly suppressed glutamate-induced apoptosis by 68% (as indicated by DNA fragmentation) in cultures containing glucose and Mg2+. Furthermore, the N-methyl-D-aspartate (NMDA) receptor antagonist AP-5 reversed QUIN-induced neuroprotection, while the non-NMDA antagonist CNQX had no effect. This study demonstrates that pathophysiologically relevant concentrations of QUIN can protect neurons from apoptosis mediated via the NMDA receptor.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Cerebellum / cytology
  • Cerebellum / drug effects*
  • Cerebellum / metabolism
  • Excitatory Amino Acid Agonists / pharmacology
  • Excitatory Amino Acid Antagonists / pharmacology
  • Glutamic Acid / pharmacology*
  • Logistic Models
  • N-Methylaspartate / pharmacology
  • Necrosis
  • Neurons / drug effects*
  • Neuroprotective Agents / pharmacology*
  • Quinolinic Acid / pharmacology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Excitatory Amino Acid Agonists
  • Excitatory Amino Acid Antagonists
  • Neuroprotective Agents
  • Glutamic Acid
  • N-Methylaspartate
  • Quinolinic Acid